Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ACADIA PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 206,884 shares of ACAD (ACADIA PHARMACEUTICALS INC), worth $4.6M as of 2026-Q1. The position was increased (+0.7% shares). ACAD represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$4.6M
Current Shares
206,884
Total Value Change
+$1.1M
Total Shares Change
-10,711
Other major holders of ACAD: CAPITAL FUND MANAGEMENT S.A., BNP PARIBAS FINANCIAL MARKETS, DnB Asset Management AS
Increased |
| 206,884 |
+0.7% |
| $4.6M |
| 0.0% |
| $22.50 |
27 |
| 2025-Q4 | Decreased | 205,433 | -2.7% | $5.5M | 0.0% | $26.70 | 0 |
| 2025-Q3 | Decreased | 211,115 | -38.4% | $4.5M | 0.0% | $21.32 | 0 |
| 2025-Q2 | Increased | 342,882 | +36.6% | $7.4M | 0.0% | $22.12 | 36 |
| 2025-Q1 | Increased | 251,056 | +14.6% | $4.2M | 0.0% | $17.07 | 31 |
| 2024-Q4 | Increased | 219,125 | +15.5% | $4M | 0.0% | $16.69 | 31 |
| 2024-Q3 | Decreased | 189,739 | -12.8% | $2.9M | 0.0% | $15.69 | 0 |
| 2024-Q2 | Increased | 217,595 | +82.3% | $3.5M | 0.0% | $16.25 | 41 |